Expanded Access of Dupilumab in Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Previously Treated With Linvoseltamab
Clinical trial NCT06631677 · AVAILABLE
Trial details
- NCT number
- NCT06631677
- Sponsor
- Regeneron Pharmaceuticals
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.